Roche Shares Gain Momentum on Portfolio Transition and Diagnostic Wins

Roche Holding AG Stock: A Defensive Powerhouse in Pharmaceuticals for North American Investors

A Paradigm Shift in Oncology: Core Stocks Roche & Galderma and the High-Leverage Opportunity in Vidac Pharma

Insight, Diagnostics Company Reach Settlement

Roche chairman still expects diagnostics hit from US tariffs

Roche Shares Fall After Breast-Cancer Treatment Misses Goal in Late-Stage Study